Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 18.770
- -0.240-1.26%
Close Dec 13 16:00 ET
- 18.770
- 0.0000.00%
Post 16:00 ET
686.54MMarket Cap-9.56P/E (TTM)
18.880High17.790Low142.07KVolume18.880Open19.010Pre Close2.61MTurnover1.54%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.12P/B172.68MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM5.73%Amplitude16.550Historical Low18.350Avg Price1Lot Size
Rapport Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | -202.64%-16.42M | -147.80%-16.35M | -266.90%-17.62M | -27.18M | -10.36M | -5.42M | -6.6M | -4.8M |
| Net income from continuing operations | -101.37%-17.54M | -182.65%-18.12M | -268.78%-22.67M | ---34.79M | ---13.52M | ---8.71M | ---6.41M | ---6.15M |
| Operating gains losses | --0 | --0 | 617.48%7.39M | --1.12M | --94K | --0 | --0 | --1.03M |
| Depreciation and amortization | 852.17%219K | 890.48%208K | 913.33%152K | --112K | --53K | --23K | --21K | --15K |
| Other non cash items | --162K | --159K | --156K | --267K | --148K | ---- | ---- | ---- |
| Change In working capital | -120.88%-477K | 89.34%-123K | -648.10%-3.16M | --2.65M | --1.94M | --2.28M | ---1.15M | ---422K |
| -Change in prepaid assets | -232.28%-672K | 173.95%900K | -241.58%-2.07M | ---3.2M | ---1.89M | --508K | ---1.22M | ---606K |
| -Change in payables and accrued expense | -79.06%364K | -2,305.00%-882K | -367.70%-953K | --6.24M | --4.1M | --1.74M | --40K | --356K |
| -Change in other current assets | --0 | 4.35%24K | 115.70%27K | ---240K | ---115K | --24K | --23K | ---172K |
| -Change in other current liabilities | -1,307.14%-169K | ---165K | ---161K | ---144K | ---158K | --14K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | -202.64%-16.42M | -147.80%-16.35M | -266.90%-17.62M | ---27.18M | ---10.36M | ---5.42M | ---6.6M | ---4.8M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -101,901.92%-53.04M | -124,439.53%-107.1M | -68,631.15%-41.93M | -78.86M | -78.66M | -52K | -86K | -61K |
| Net PPE purchase and sale | -169.23%-140K | -1,024.42%-967K | -1,657.38%-1.07M | ---1.64M | ---1.44M | ---52K | ---86K | ---61K |
| Net investment purchase and sale | ---52.9M | ---106.14M | ---40.85M | ---77.22M | ---77.22M | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -101,901.92%-53.04M | -124,439.53%-107.1M | -68,631.15%-41.93M | ---78.86M | ---78.66M | ---52K | ---86K | ---61K |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | -101.63%-1.39M | 177,158.89%159.35M | 6.09%63.66M | 145.14M | -140K | 85.36M | -90K | 60.01M |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | -34,750.00%-1.39M | 530,230.00%159.1M | --0 | --50K | --0 | ---4K | --30K | --24K |
| Net preferred stock issuance | --0 | 63.75%-29K | 6.57%63.94M | --145.22M | ---6K | --85.31M | ---80K | --60M |
| Net other financing activities | ---- | ---- | -1,472.22%-283K | ---134K | ---- | ---- | ---40K | ---18K |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | -101.63%-1.39M | 177,158.89%159.35M | 6.09%63.66M | --145.14M | ---140K | --85.36M | ---90K | --60.01M |
| Net cash flow | ||||||||
| Beginning cash position | 38.65%110.27M | -13.82%74.37M | 125.47%70.25M | --31.16M | --159.41M | --79.53M | --86.3M | --31.16M |
| Current changes in cash | -188.69%-70.85M | 629.85%35.9M | -92.53%4.12M | --39.1M | ---89.16M | --79.88M | ---6.78M | --55.14M |
| End cash Position | -75.27%39.42M | 38.65%110.27M | -13.82%74.37M | --70.25M | --70.25M | --159.41M | --79.53M | --86.3M |
| Free cash flow | -202.32%-16.56M | -159.07%-17.32M | -284.35%-18.69M | ---28.82M | ---11.79M | ---5.48M | ---6.69M | ---4.86M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.